The EMA is expected to approve the J&J single injection vaccine



[ad_1]

The European Medicines Agency is expected to clear the way for the European Commission to approve the Covid-19 vaccine made by Janssen, a Johnson & Johnson subsidiary, later today.

It will be the fourth coronavirus vaccine approved for use in Europe.

The Government expects Ireland to receive 600,000 doses of this new vaccine during the second half of the year.

The jab only requires a single injection and is therefore faster and easier to administer than vaccines already in use.

It’s also easier to transport as it doesn’t have to be frozen and is effective for all age groups.

The US Food and Drug Administration approved it 12 days ago, and the European Medicines Agency is expected to do the same later today.

They have been evaluating data and laboratory studies on how well the vaccine works and how safe it is for months.

If, as expected, the EMA concludes that the benefits of the new vaccine outweigh the risks, it will recommend the Conditional Marketing Authorization, clearing the way for the European Commission to authorize its use, possibly as early as tomorrow.



[ad_2]